{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:20:48Z","timestamp":1777868448572,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.clineuro.2026.109382","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:09:58Z","timestamp":1772842198000},"page":"109382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Protein A immunoadsorption for refractory neuromyelitis optica spectrum disorder: A prospective single-center study"],"prefix":"10.1016","volume":"265","author":[{"given":"Youjia","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miaochang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songbao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9241-6094","authenticated-orcid":false,"given":"Xiaoyan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clineuro.2026.109382_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.clineuro.2026.109382_bib2","article-title":"Collaborative international research in clinical and longitudinal experience study in NMOSD","volume":"6","author":"Cook","year":"2019","journal-title":"Neurol. (R. ) Neuroimmunol. & Neuroinflamm."},{"key":"10.1016\/j.clineuro.2026.109382_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/460825","article-title":"Neuromyelitis optica: an antibody-mediated disorder of the central nervous system","volume":"2012","author":"Oh","year":"2012","journal-title":"Neurol. Res. Int."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109382_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jca.21965","article-title":"A prospective study on tryptophan immunoadsorption in AQP4 antibody-positive neuromyelitis optica spectrum disorders","volume":"37","author":"Liu","year":"2022","journal-title":"J. Clin. Apher."},{"issue":"6","key":"10.1016\/j.clineuro.2026.109382_bib5","article-title":"Apheresis therapies for NMOSD attacks: a retrospective study of 207 therapeutic interventions","volume":"5","author":"Kleiter","year":"2018","journal-title":"Neurol. (R. ) Neuroimmunol. & Neuroinflamm."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109382_bib6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/WCO.0000000000000694","article-title":"Neuromyelitis optica spectrum disorders: still evolving and broadening","volume":"32","author":"Fujihara","year":"2019","journal-title":"Curr. Opin. Neurol."},{"issue":"2","key":"10.1016\/j.clineuro.2026.109382_bib7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.24554","article-title":"Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses","volume":"79","author":"Kleiter","year":"2016","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.clineuro.2026.109382_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9103211","article-title":"Apheresis in neurological disorders","volume":"9","author":"Dorst","year":"2020","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.clineuro.2026.109382_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the American Society for Apheresis: The Ninth Special Issue","volume":"38","author":"Connelly-Smith","year":"2023","journal-title":"J. Clin. Apher."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109382_bib10","article-title":"A case of anti-aquaporin-4 antibody-positive optic neuritis treated by selective immunoadsorption","volume":"60","author":"Naganuma","year":"2021","journal-title":"Transfus. Apher. Sci. Off. J. World Apher. Assoc. Off. J. Eur. Soc. Haemapher."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109382_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/1756285616646332","article-title":"Immunoadsorption in patients with neuromyelitis optica spectrum disorder","volume":"9","author":"Faissner","year":"2016","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109382_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/vox.12191","article-title":"The effect of immunoadsorption with the Immusorba TR-350 column on coagulation compared to plasma exchange","volume":"108","author":"Koessler","year":"2015","journal-title":"Vox Sang."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109382_bib13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/jca.21686","article-title":"Immunoadsorption or plasma exchange in steroid-refractory multiple sclerosis and neuromyelitis optica","volume":"34","author":"Lipphardt","year":"2019","journal-title":"J. Clin. Apher."},{"key":"10.1016\/j.clineuro.2026.109382_bib14","doi-asserted-by":"crossref","DOI":"10.1177\/17562864221150314","article-title":"Immunoadsorption as maintenance therapy for refractory neuromyelitis optica spectrum disorder","volume":"16","author":"Heigl","year":"2023","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.clineuro.2026.109382_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117568","article-title":"Protein A immunoadsorption for the treatment of refractory anti-N-methyl-d-aspartate receptor encephalitis: a single-center prospective study","volume":"428","author":"Zhang","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109382_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/vox.13205","article-title":"Profile of the single-use, multiple-pass protein A adsorber column in immunoadsorption","volume":"117","author":"Schossee","year":"2022","journal-title":"Vox Sang."},{"key":"10.1016\/j.clineuro.2026.109382_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1429405","article-title":"Protein-A immunoadsorption combined with immunosuppressive treatment in refractory primary Sj\u00f6gren's syndrome coexisting with NMOSD: a case report and literature review","volume":"15","author":"Fan","year":"2024","journal-title":"Front Immunol."},{"issue":"5","key":"10.1016\/j.clineuro.2026.109382_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1212\/WNL.0000000000002366","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"86","author":"Tan","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.clineuro.2026.109382_bib19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1055\/s-0032-1333539","article-title":"Diagnosis and management of common acquired bleeding disorders","volume":"39","author":"De Simone","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109382_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12974-022-02420-2","article-title":"Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort study","volume":"19","author":"Demuth","year":"2022","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109382_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00415-023-11910-z","article-title":"Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: attack therapy and long-term management","volume":"271","author":"K\u00fcmpfel","year":"2024","journal-title":"J. Neurol."},{"issue":"9","key":"10.1016\/j.clineuro.2026.109382_bib22","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clineuro.2026.109382_bib23","article-title":"Dynamic changes in AQP4-IgG level and immunological markers during protein-A immunoadsorption therapy for NMOSD: a case report and literature review","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109382_bib24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/jnnp-2017-316286","article-title":"Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders","volume":"89","author":"Bonnan","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clineuro.2026.109382_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112796","article-title":"A short-term functional recovery comparison of therapeutic plasma exchange and immunoadsorption in severe acute neuroimmune diseases","volume":"140","author":"Leng","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109382_bib26","article-title":"More efficient complement activation by anti-aquaporin-4 compared with anti-myelin oligodendrocyte glycoprotein antibodies","volume":"10","author":"Lerch","year":"2023","journal-title":"Neurol. (R. ) Neuroimmunol. & Neuroinflamm."},{"issue":"Pt 2","key":"10.1016\/j.clineuro.2026.109382_bib27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain a J. Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109382_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jca.2920090109","article-title":"Protein A immunoadsorption treatment in hematology: an overview","volume":"9","author":"Howe","year":"1994","journal-title":"J. Clin. Apher."},{"issue":"5","key":"10.1016\/j.clineuro.2026.109382_bib29","first-page":"671","article-title":"Immunoadsorption in neurological disorders","volume":"56","author":"Oji","year":"2017","journal-title":"Transfus. Apher. Sci. Off. J. World Apher. Assoc. Off. J. Eur. Soc. Haemapher."},{"issue":"11","key":"10.1016\/j.clineuro.2026.109382_bib30","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1177\/1352458512443917","article-title":"Quantitative assays for anti-aquaporin-4 antibody with subclass analysis in neuromyelitis optica","volume":"18","author":"Isobe","year":"2012","journal-title":"Mult. Scler. (Houndmills Basingstoke Engl. )"},{"key":"10.1016\/j.clineuro.2026.109382_bib31","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3389\/fimmu.2018.01438","article-title":"Aquaporin-4 autoantibodies from neuromyelitis optica spectrum disorder patients induce complement-independent immunopathologies in mice","volume":"9","author":"Yick","year":"2018","journal-title":"Front. Immunol."},{"issue":"1-2","key":"10.1016\/j.clineuro.2026.109382_bib32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jneuroim.2014.07.001","article-title":"Complement activation in patients with neuromyelitis optica","volume":"274","author":"Nytrova","year":"2014","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109382_bib33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/08830185.2020.1833877","article-title":"Complement system network in cell physiology and in human diseases","volume":"40","author":"Romano","year":"2021","journal-title":"Int. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109382_bib34","first-page":"360","article-title":"Removal characteristics of immunoadsorption with the immusorba TR-350 column using conventional and selective plasma separators","volume":"20","author":"Ohkubo","year":"2016","journal-title":"Ther. Apher. Dial. Off. PeerRev. J. Int. Soc. Apher. Jpn. Soc. Apher. Jpn. Soc. Dial. Ther."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846726000740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846726000740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T11:57:49Z","timestamp":1777550269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846726000740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":34,"alternative-id":["S0303846726000740"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2026.109382","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein A immunoadsorption for refractory neuromyelitis optica spectrum disorder: A prospective single-center study","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2026.109382","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109382"}}